• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of Zhejiang University(Medical Sciences)

    Journal of Zhejiang University(Medical Sciences)

    JournalISSN 2097-5171

    年发文量

    研究主题

    论文(3037)

    排序
    1Serum Metabolomics-Based Investigation of the Mechanism by Which Polysaccharides from the Erxian Herb Pair Ameliorate Osteoblast Apoptosis Via the PI3K/AKT/mTOR Signaling Pathway
    Yun ZHOU, Qitao YE,Mengying LI,Ruyi CHEN,Yang ZHANG, Qinyang CAI,Dan SHOU
    2026
    引用
    AI阅读
    加入学术空间
    2Practical Foundations and Construction Pathways of China's Living Will System: a Comparative Law Perspective
    Meng LIU, Xin LI

    Living wills serve as an institutional link connecting medical self-determination, respect for life's dignity, family care ethics, and palliative care. China's existing law already provides a normative foundation through provisions on the right to life, informed consent, emergency rescue, voluntary guardianship, and medical quality management. These rules, however, remain fragmented and are insufficient to address the preservation of patients' authentic wishes, the boundaries of relatives' participation, the liability risks faced by medical institutions, and dispute resolution. A China-specific living will system should take the priority of the patient's own directive as its core rule and confine family involvement to a procedural mechanism for confirming, interpreting, and supporting the patient's wishes. Specifically, building on existing normative resources, the system should clarify the priority effect of living wills over medical decisions and limit their scope to major medical matters in specified serious life-threatening conditions; improve the rules on making, modifying, and revoking living wills; and safeguard implementation through physician review, ethics review, medical record documentation, and liability allocation. In this way, living wills can be embedded in China's existing health law system, yielding an institutional arrangement that is both locally adaptable and clinically operational.

    2026
    引用
    AI阅读
    加入学术空间
    3Ethical Dilemmas of the Personalized Patient Preference Predictor in Family-Based Surrogate Decision-Making in China
    Leqian WU, Bin WANG, Xinyu CHEN

    When patients lack decision-making capacity, identifying, interpreting, and giving effect to their wishes remains a central challenge in surrogate decision-making. The personalized patient preference predictor (P4) seeks to support preference identification through large language models. However, patient preferences are closely tied to life experience, family relationships, and the care situation, and cannot be adequately understood from digital traces alone. In family-based surrogate decision-making in China, P4 may reproduce existing biases embedded in its training data; expanding the use of private data to improve accuracy may also exceed the scope of patient authorization and increase the risk of privacy violations. Its data use should therefore follow the principle of data minimization, its predictions should be interpreted in conjunction with clinical judgment and within family deliberation, and patients' clearly expressed prior wishes and best interests should serve as fundamental limits. Moreover, predictive accuracy does not by itself confer normative authority: over-reliance on algorithmic outputs may narrow the space for deliberation and obscure where responsibility lies. P4 should therefore be positioned as an accountable, contestable, and constrained input to family deliberation. Clarifying the responsibilities of the parties involved, establishing procedures for objection and review, and defining limits on use can help safeguard patient dignity and preserve the space for deliberation. Drawing on the norms of patient autonomy, substituted judgment, and the best-interests standard, this article analyzes the ethical dilemmas that arise when P4 is introduced into family-based surrogate decision-making in China, and examines its normative status and procedural safeguards.

    2026
    引用
    AI阅读
    加入学术空间
    4Effects of Aerobic Exercise on Reproductive Hormone Profiles in Women with Polyendocrine Metabolic Ovarian Syndrome (polycystic Ovary Syndrome): a Meta-Analysis
    Mingnan ZHUANG, Zongnan LIU, Henghao YAN,Mingyue YIN, Yilin ZHANG, Donglin SHI
    2026
    引用
    AI阅读
    加入学术空间
    5Latent Classes of Employment Status, Social Support, and Environmental Risk Exposure and Their Associations with Psychological Adaptation among Community-Based Drug Rehabilitation Participants
    Zhenming DING, Xin YE, Yang LI,Liangliang CHEN
    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3037 篇论文

    高被引作者

    作者引用发文
    He Huang99429
    Jianying Zhou98010
    Qiang Fang9766
    HongLiu Cai9756
    Tingbo Liang9738
    Kaijin Xu9318
    Jifang Sheng9225
    Yihong Shen9194
    Shaohua Hu9184
    Qin Ni9175

    高产作者

    作者引用发文
    Erqing Wei39958
    Jie Yan40142
    Zhong Chen43642
    Qiang Xia28241
    Min Lou28635
    Yunbi Lu21730
    Hangping Yao24030
    Hefeng Huang20129
    He Huang99429
    Weiping Zhang20829

    相关期刊

    Zhong nan da xue xue bao. Yi xue ban
    Current Medical Science
    Journal of Southern Medical University
    Chinese journal of cellular and molecular immunology
    Journal of Medical Postgraduates
    Chinese bulletin of Life sciences
    Medical Journal of Chinese People's Liberation Army
    Chinese Journal of Cell Biology
    Journal of Jiangsu University(Medicine Edition)
    四川大学学报(医学版)